Patel, Viral
Elias, Roy https://orcid.org/0000-0002-8555-4322
Formella, Joseph https://orcid.org/0000-0002-1846-8133
Schwartzman, William
Christie, Alana
Cai, Qi
Malladi, Venkat https://orcid.org/0000-0002-0144-0564
Kapur, Payal
Vazquez, Miguel
McKay, Renee
Pedrosa, Ivan
Hannan, Raquibul https://orcid.org/0000-0003-1282-056X
Hammers, Hans
Brugarolas, James https://orcid.org/0000-0002-8575-499X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma
https://doi.org/10.1136/jitc-2020-001198
Funding for this research was provided by:
Burroughs Wellcome Fund
American Cancer Society (RSG-16-004-01-CCE)
Cancer Prevention and Research Institute of Texas (RP150596)
National Cancer Institute (P50CA196516)
National Institute of Diabetes and Digestive and Kidney Diseases (UH3DK104655)
National Institute of Diabetes and Digestive and Kidney Diseases (UH3DK114870)